Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Benchmark Downgrades New Oriental Education to Hold

Benchmark analyst Fawne Jiang downgrades New Oriental Education (NYSE:EDU) from Buy to Hold.
byBenzinga Newsdesk
July 26, 2021
1 minute read
Total
0
Shares
0
0
0
0
0
0

Benchmark analyst Fawne Jiang downgrades New Oriental Education (NYSE:EDU) from Buy to Hold.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Immutep Announced it Will Evaluate Efti in Triple Combination Therapy Phase I Study with Chemotherapy and an anti-PD-1 Therapy

By Charles Gross
Today, 11:46 PM
Immutep Limited (NASDAQ: IMMP) announces it has signed an agreement to commence a new Phase I trial, called INSIGHT-003, to evaluate the combination of lead product candidate eftilagimod alpha ("efti" or "IMP321") in conjunction with an existing approved standard of care therapy consisting of a chemotherapy agent and ananti-P

IMMP